Abstract: The present invention describes a pharmaceutical preparation in which a reactive chlorine-oxygen compound is provided in the form of a medicament inhalable into the lungs.

Abstract: The present invention describes a pharmaceutical preparation for use in the treatment of systemic inflammatory response syndrome (SIRS).

Abstract: The invention relates to a pharmaceutically active substance comprising at least one peptide portion having the amino acid sequences m-v-v-y-f-r (first peptide portion), characterised in that the pharmaceutically active substance comprises at least additional one amino acid and/or peptide portion at the N-terminal end and/or at the C-terminal end of the first peptide portion (second peptide portion and/or third peptide portion) being directly bound to the peptide portion having the amino acid sequences m-v-v-y-f-r (first peptide portion). The invention further relates to a pharmaceutical composition and a drug for the treatment of cancer.

Abstract: A device for providing a skin or wound dressing, a wound treatment set, and a method to provide a skin or wound dressing, wherein the skin or wound dressing includes an active substance, and wherein the device comprises at least two chambers for the storage of at least two liquids, which are openable by mechanical action, so that, after opening of the chambers, the liquids are miscible and are transferrable to an active substance carrier.

Abstract: A trusted battery meter and battery monitoring system is described, including: a battery comprising one or more cells; at least one battery parameter sensor, the sensor operatively associated with the battery and a sensor board, the sensor board receiving data relative to plural sensors associated with one or more battery cells and plural types of battery parameters; and a processor configured to process battery sensor input as defined assets, to paraphrase said sensor input in a node as data usable for a smart contract, the smart contract being a function within a blockchain acting in an autonomous way on processing given input to given output according to a desired interval, providing a transaction as an output of the smart contract, which transaction is validated and included into the blockchain; wherein the blockchain provides trusted, updated data for current battery status and SoH determinations and for changes in battery SoH over time.

Abstract: A method for the isolation of specific molecules which bind highly selectively to chosen target molecules. In particular, due to displacement with a specific competitor, binding molecules are selected which preferably bind to previously known epitopes.

Abstract: The invention relates to the use of dichloric acids and the derivatives thereof for producing medicaments used for disinfecting body cavities.

Abstract: Specific amino acid sequences and peptides and/or peptide mimetics deducted therefrom influencing apoptosis, and the use thereof for the production of pharmaceuticals as diagnostic tools are shown.

Abstract: This invention relates to aqueous solutions of reactive chlorine compounds having the empirical formulae H2Cl2O6 or ClO3H, for example, and the derivatives, anions or salts thereof. The invention further relates to methods for the production of said compounds and the use thereof in the pharmaceutical and particularly in the medical field, in cosmetics, medicinal care and in the domains of food technology and technology.

Abstract: This invention relates to aqueous solutions of reactive chlorine compounds having the empirical formulae H2Cl2O6 or ClO3H, for example, and the derivatives, anions or salts thereof. The invention further relates to methods for the production of said compounds and the use thereof in the pharmaceutical and particularly in the medical field, in cosmetics, medicinal care and in the domains of food technology and technology.

Abstract: The invention relates to a method for identifying substances with antiapoptotic activity, where i) cells which express both CD47 and the integrin ?v?3 are cultured, ii) the cells are caused to produce an apoptosis-inducing substance, and/or a substance or substances which induces/induce apoptosis is/are added, iii) the test substance is added, and iv) the apoptosis rate is measured, and to the substances which can be identified with the method.

Abstract: The invention relates to a method for identifying substances with antiapoptotic activity, where i) cells which express both CD47 and the integrin ?v?3 are cultured, ii) the cells are caused to produce an apoptosis-inducing substance, and/or a substance or substances which induces/induce apoptosis is/are added, iii) the test substance is added, and iv) the apoptosis rate is measured, and to the substances which can be identified with the method.

Abstract: Specific amino acid sequences and peptides and/or peptide mimetics deducted therefrom influencing apoptosis, and the use thereof for the production of pharmaceuticals as diagnostic tools are shown.

Abstract: Specific amino acid sequences and peptides and/or peptide mimetics deducted therefrom influencing apoptosis, and the use thereof for the production of pharmaceuticals as diagnostic tools are shown.

Abstract: The invention relates to the use of substances as a fundamental constituent in wound healing agents. The invention is characterized in that said substances bond to either IAP and/or integrin ?v?3 and/or thrombospondin-1 in such a way that the bond between thrombospondin-1 and IAP and/or integrin ?v?3 is inhibited.

Abstract: This invention relates to aqueous solutions of reactive chlorine compounds having the empirical formulae H2Cl2O6 or ClO3H, for example, and the derivatives, anions or salts thereof. The invention further relates to methods for the production of said compounds and the use thereof in the pharmaceutical and particularly in the medical field, in cosmetics, medicinal care and in the domains of food technology and technology.

Abstract: The invention relates to anti-apoptotically active apatamers. The invention describes possible therapeutic and diagnostic applications for, among other things, treating arteriosclerosis, promoting the healing of wounds, treating AIDS, cancer, Alzheimer's disease, systemic lupus erythematosus as well a rheumatoid arthritis and other chronic inflammatory diseases.

Abstract: This invention relates to aqueous solutions of reactive chlorine compounds having the empirical formulae H2Cl2O6 or ClO3H, for example, and the derivatives, anions or salts thereof. The invention further relates to methods for the production of said compounds and the use thereof in the pharmaceutical and particularly in the medical field, in cosmetics, medicinal care and in the domains of food technology and technology.

Abstract: The invention relates to the use of substances as a fundamental constituent in wound healing agents. The invention is characterised in that said substances bond to either IAP and/or integrin ?v?3 and/or thrombuspondin-1 in such a way that the bond between thrumbospondin-1 and IAP and/or integrin ?v?3 is inhibited.

Abstract: The invention relates to a method for identifying substances with antiapoptotic activity, where i) cells which express both CD47 and the integrin ?v?3 are cultured, ii) the cells are caused to produce an apoptosis-inducing substance, and/or a substance or substances which induces/induce apoptosis is/are added, iii) the test substance is added, and iv) the apoptosis rate is measured, and to the substances which can be identified with the method.